Northern Trust Corp Mirati Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$41.99 - $62.38 $552,168 - $820,297	13,150 Added 5.46%	253,930 $14.9 Million
Q3 2023 Nov 13, 2023	BUY	$27.8 - $45.35 $723,411 - $1.18 Million	26,022 Added 12.12%	240,780 $10.5 Million
Q2 2023 Aug 11, 2023	BUY	$36.13 - $49.49 $402,885 - $551,862	11,151 Added 5.48%	214,758 $7.76 Million
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $349,833 - $519,485	9,574 Added 4.93%	203,607 $7.57 Million
Q4 2022 Feb 13, 2023	SELL	$41.27 - $98.62 $143,867 - $343,789	-3,486 Reduced 1.76%	194,033 $8.79 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $344,029 - $501,299	5,782 Added 3.02%	197,519 $13.8 Million
Q2 2022 Aug 12, 2022	SELL	$39.16 - $88.71 $331,959 - $751,994	-8,477 Reduced 4.23%	191,737 $12.9 Million
Q1 2022 May 13, 2022	BUY	$75.82 - $150.97 $135,262 - $269,330	1,784 Added 0.9%	200,214 $16.5 Million
Q4 2021 Feb 08, 2022	BUY	$132.01 - $190.29 $1.15 Million - $1.66 Million	8,729 Added 4.6%	198,430 $29.1 Million
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $5.68 Million - $7.62 Million	-42,959 Reduced 18.46%	189,701 $33.6 Million
Q2 2021 Aug 13, 2021	SELL	$144.0 - $179.73 $34.9 Million - $43.6 Million	-242,310 Reduced 51.02%	232,660 $37.6 Million
Q1 2021 May 12, 2021	SELL	$158.92 - $221.61 $3.19 Million - $4.45 Million	-20,102 Reduced 4.06%	474,970 $81.4 Million
Q4 2020 Feb 11, 2021	BUY	$162.05 - $240.27 $8.39 Million - $12.4 Million	51,775 Added 11.68%	495,072 $109 Million
Q3 2020 Nov 16, 2020	SELL	$113.26 - $167.27 $2.16 Million - $3.19 Million	-19,081 Reduced 4.13%	443,297 $73.6 Million
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $5.88 Million - $9.83 Million	81,667 Added 21.45%	462,378 $52.8 Million
Q1 2020 May 14, 2020	BUY	$69.78 - $116.21 $2.38 Million - $3.96 Million	34,083 Added 9.83%	380,711 $29.3 Million
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $706,680 - $1.29 Million	-9,987 Reduced 2.8%	346,628 $44.7 Million
Q3 2019 Nov 13, 2019	BUY	$77.91 - $109.6 $4.5 Million - $6.33 Million	57,731 Added 19.32%	356,615 $27.8 Million
Q2 2019 Aug 13, 2019	BUY	$59.49 - $104.71 $405,602 - $713,912	6,818 Added 2.33%	298,884 $30.8 Million
Q1 2019 May 13, 2019	BUY	$43.65 - $78.95 $767,847 - $1.39 Million	17,591 Added 6.41%	292,066 $21.4 Million
Q4 2018 Feb 12, 2019	BUY	$32.0 - $47.43 $46,208 - $68,488	1,444 Added 0.53%	274,475 $11.6 Million
Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $1.2 Million - $1.6 Million	25,499 Added 10.3%	273,031 $12.9 Million
Q2 2018 Sep 18, 2018	SELL	$26.05 - $52.4 $21,803 - $43,858	-837 Reduced 0.34%	247,532 $12.2 Million
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $4.9 Million - $9.85 Million	188,028 Added 311.61%	248,369 $12.2 Million
Q1 2018 May 09, 2018	BUY	$17.2 - $34.95 $89,388 - $181,635	5,197 Added 9.42%	60,341 $1.85 Million
Q4 2017 Feb 14, 2018	BUY	$12.65 - $19.0 $22,048 - $33,117	1,743 Added 3.26%	55,144 $1.01 Million
Q3 2017 Nov 13, 2017	BUY	$4.7 - $11.7 $250,984 - $624,791	53,401	53,401 $625,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account